MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
0.7204
-0.0135 (-1.84%)
At close: Feb 13, 2026, 4:00 PM EST
0.7196
-0.0008 (-0.11%)
After-hours: Feb 13, 2026, 5:56 PM EST

MaxCyte Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-45.63-41.06-37.92-23.57-19.08-11.82
Depreciation & Amortization
5.024.794.572.71.421.05
Loss (Gain) From Sale of Assets
0.630.920.120.220.080.11
Loss (Gain) From Sale of Investments
-3.41-6.24-7.12-2.67-0.07-0
Stock-Based Compensation
11.6413.0813.9811.757.962.47
Provision & Write-off of Bad Debts
0.03-0.130.17---0.12
Other Operating Activities
1.461.770.70.770.650.39
Change in Accounts Receivable
-3.771.237.14-6.48-1.71-1.81
Change in Inventory
1.171.36-4.53-3.49-1.41-0.89
Change in Accounts Payable
-3.8-1.883.25-0.152.090.39
Change in Unearned Revenue
-1.480.18-1.64-0.031.91.65
Change in Other Net Operating Assets
-1.42-1.64-0.396.18-2.53-0.2
Operating Cash Flow
-39.54-27.61-21.69-14.78-10.68-8.78
Capital Expenditures
-1.68-1.65-3.7-18.48-3.83-2.07
Sale of Property, Plant & Equipment
--0.01-0-
Investment in Securities
18.058.5858.68-6.35-191.18-14.51
Investing Cash Flow
14.596.9354.98-24.82-195.01-16.58
Long-Term Debt Issued
-----1.44
Long-Term Debt Repaid
-----4.99-1.5
Net Debt Issued (Repaid)
-----4.99-0.06
Issuance of Common Stock
0.962.062.142.89239.7128.97
Financing Cash Flow
0.962.062.142.89234.7228.9
Net Cash Flow
-23.99-18.6235.44-36.7229.033.54
Free Cash Flow
-41.23-29.26-25.39-33.26-14.51-10.85
Free Cash Flow Margin
-119.78%-75.75%-61.48%-75.14%-42.82%-41.48%
Free Cash Flow Per Share
-0.39-0.28-0.25-0.33-0.16-0.16
Cash Interest Paid
----0.420.42
Levered Free Cash Flow
-18.35-13.24-10.51-30.49-6.82-6.39
Unlevered Free Cash Flow
-18.35-13.24-10.51-30.49-6.57-6.1
Change in Working Capital
-9.3-0.753.82-3.98-1.64-0.86
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q